A Nigerian professor of veterinary medicine and clinical virology, Prof. Maduike Ezeibe, has discovered a permanent cure for the treatment and cure for the Human Immunodeficiency Virus (HIV) and the Acquired Immune Deficiency Syndrome (AIDS).
The Vice Chancellor of the Michael Okpara University of Agriculture, Umudike, Abia State, Prof. Francis Otunta, said the new drug was developed by a staff of the institution.
Otunta disclosed in Umudike that the breakthrough made by Ezeibe, a professor and researcher in the University. followed years of scientific research by the institution.
He explained that Ezeibe had presented the drug to the university management, senate and council, and had also disclosed the processes he undertook to arrive at his research.
“Ezeibe has brought honour to the university. Professor Ezeibe is a researcher in Veterinary Medicine and one may wonder how he discovered a drug to cure a human ailment.”
He noted that the professor’s finding was not contradicted when he presented the drug to his colleagues in the medical field.
Otunta remarked that the university is in the process of mass producing the drug for further clinical trials on persons living with HIV/AIDS in the country.
Speaking on the breakthrough, Ezeibe, a professor of veterinary medicine and clinical virology, revealed that the drug was produced with Aluminum Silicate and Magnesium Silicate (Synthetic Aluminum-Magnesium Silicate).
He said both minerals “are already in use as medicines for the treatment of various animal and human diseases.”
The professor added that 10 persons living with the disease had shown interests and were made to apply through their doctor to the VC.
“They were treated daily with the Medicinal Synthetic Aluminum-Magnesium Silicate (50 mg/kg),” he said.
“The volunteers were subjected to monthly tests for viral loads and CD4-lymphocyte counts.
“With the antiviral effects of the medicine, its ability to reach all cells (as nanoparticles) and the lymphocytes, there is no more hiding place (sanctuary) for HIV.”
He said the medicine had been used to “potentiate Ampicilin, Chloroquine, Piperazine and Sulphadimidin, among others, and could be a major foreign exchange earner for Nigeria, if approved by relevant authorities.
“Local and international pharmaceutical companies would find the product as a veritable raw material.”
Ezeibe noted that research findings was presented to the world virology conference in Atlanta in 2015, and Antonio (Texas), in 2016.
“Besides, the esults of the laboratory tests had been published in many international scientific journals, including the British Journal of Medicine and Medical Research.
“If commercialised, the Medicinal Synthetic Aluminum- Magnesium Silicate would become an alternative for petroleum to the Nigerian economy.” he added.
By Our Correspondent